---
document_datetime: 2026-01-19 13:25:28
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/teduglutide-viatris-epar-all-authorised-presentations_en.pdf
document_name: teduglutide-viatris-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3790227
conversion_datetime: 2026-01-20 20:24:44.817468
docling_version:
  docling-serve: 1.10.0
  docling-jobkit: 1.8.1
  docling: 2.69.0
  docling-core: 2.60.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Content (concentration) Pack size

EU/1/25/2005/001 Teduglutide Viatris 5 mg Powder and solvent for solution for injection Subcutaneous use powder: vial (glass); solvent: pre-filled syringe (glass) powder: 5 mg; solvent: 0.5 ml (10 mg/ml) 28 vials + 28 prefilled syringes